Dumbrava identifies the TP53 gene, known as the 'guardian of the genome,' as a potential future target for targeted therapies.

Authors

• Person: Not available Organization: MD Anderson Cancer Center
  Clinical Center for Targeted Therapy | UT MD Anderson

Sources

• Clinical Center for Targeted Therapy | UT MD Anderson www.mdanderson.org MD Anderson Cancer Center via serper

Referenced by nodes (2)

• TP53 concept
• targeted cancer therapy concept